Le rôle prépondérant des IgA dans la réponse immunitaire précoce contre le SARS-CoV-2
Open Access
- 1 November 2021
- journal article
- editorial
- Published by EDP Sciences in médecine/sciences
- Vol. 37 (11), 968-970
- https://doi.org/10.1051/medsci/2021154
Abstract
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santéKeywords
Funding Information
- ANR (Flash COVID)
This publication has 8 references indexed in Scilit:
- Enhanced SARS-CoV-2 neutralization by dimeric IgAScience Translational Medicine, 2021
- IgA dominates the early neutralizing antibody response to SARS-CoV-2Science Translational Medicine, 2021
- When Therapeutic IgA Antibodies Might Come of AgePharmacology, 2020
- A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2Nature, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- CCR10 and its ligands in regulation of epithelial immunity and diseasesProtein & Cell, 2012
- Secretory IgA antibodies provide cross‐protection against infection with different strains of influenza B virusJournal of Medical Virology, 2004
- Intracellular Neutralization of Sendai and Influenza Viruses by IgA Monoclonal AntibodiesAdvances in Experimental Medicine and Biology, 1995